Weekly semaglutide can help people living with type 1 diabetes “reach their blood sugar and weight goals”, new research has shown.
Researchers have discovered that adults with type 1 diabetes who use automated insulin delivery systems can benefit from using semaglutide.
Initially used to treat type 2 diabetes, semaglutide now also helps to treat obesity.
People using the jab can lose up to 20% of their body weight due to the drug suppressing the hunger hormone, meaning you feel full for longer and eat less.
- Combination therapy improves health outcomes for teenagers with type 1 diabetes
- Immunotherapy drug to be tested on people with type 1 diabetes for the first time
- Study to determine if type 1 diabetes can be treated with osteoporosis medication
During the study, the team of researchers analysed the health of 72 people, all of whom had type 1 diabetes.
A total of 36% of the participants using semaglutide lost up to 5% of their body weight and improved their blood glucose levels, the findings have identified.
First author Dr Andrew Ahmann said: “Semaglutide helped more people reach their blood sugar and weight goals without decreasing blood sugar.”
Over the six-month trial, the participants on semaglutide lost an average of 18.5 pounds, the study has reported.
Read the study in NEJM Evidence.
